Phase II study of first-line combined chemotherapy bevacizumab with modified RPMI regimen for elderly or frail patients with unresectable or metastatic colorectal cancer (OGSG0802)

被引：0

作者：

Iwamoto, Shigeyoshi

Kato, Takeshi

Yoshida, Motoki

Miyake, Yasuhiro

Nakamura, Masato

Satoh, Taroh

Sakai, Daisuke

Matsuoka, Masaki

Otsuji, Toshio

Furukawa, Hiroshi

机构：

[1] Kansai Med Univ, Hirakata Hosp, Hirakata, Osaka, Japan

[2] Minoh City Hosp, Osaka, Japan

[3] Osaka Med Coll Hosp, Osaka, Japan

[4] Minoh City Hosp, Mino, Japan

[5] Aizawa Hosp, Matsumoto, Nagano, Japan

[6] Kinki Univ, Sch Med, Dept Med Oncol, Osaka 589, Japan

[7] Osaka Univ, Osaka, Japan

[8] Dongo Hosp, Yamatotakada, Japan

[9] Sakai Municipal Hosp, Dept Surg, Sakai, Osaka, Japan

来源：

关键词：

D O I：

10.1200/jco.2013.31.4_suppl.573

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

573

引用

页数：1